Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors-Reference-Cited by-同舟云学术

Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

Published:2010-01-12 Issue:4 Volume:101 Page:1059-1066
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Berger Regina,Fiegl Heidi,Goebel Georg,Obexer Petra,Ausserlechner Michael,Doppler Wolfgang,Hauser-Kronberger Cornelia,Reitsamer Roland,Egle Daniel,Reimer Daniel,Müller-Holzner Elisabeth,Jones Allison,Widschwendter Martin

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01491.x/fullpdf

Reference26 articles.

1. Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9;Takeshita;Semin Immunol,2004

2. Immunotherapeutic uses of CpG oligodeoxynucleotides;Klinman;Nat Rev Immunol,2004

3. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients;Fiegl;Cancer Res,2005

4. DNA methylation in serum of breast cancer patients: An independent prognostic marker;Müller;Cancer Res,2003

5. DNA hypomethylation is prevalent even in low-grade breast cancers;Jackson;Cancer Biol Ther,2004

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling;Cell Biochemistry and Biophysics;2024-08-07

2. Understanding the Role of Toll-Like Receptors 9 in Breast Cancer;Cancers;2024-07-27

3. The Impact of TLR9 Expression Loss on Breast Cancer Tumor Cells;2024-07-06

4. Toll-like receptors in breast cancer immunity and immunotherapy;Frontiers in Immunology;2024-06-06

5. TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development;Cells;2024-01-02